Medplus Health Services Ltd

Medplus Health Services Ltd

₹ 704 3.02%
14 Nov - close price
About
Key Points

India's Leading Pharmacy Company[1][2]
MedPlus is the 2nd largest pharmacy retailer in India, with 4,552 stores across 12 states and 1 union territory as of Q2 FY25. These stores are strategically distributed to maintain a high presence in metro, tier-one, and tier-two cities.

  • Store Distribution by Region[1]
  • Telangana: 679 stores
  • Andhra Pradesh: 454 stores
  • Karnataka: 893 stores
  • Tamil Nadu: 845 stores
  • West Bengal: 506 stores
  • Maharashtra: 553 stores
  • Odisha: 149 stores
  • Chhattisgarh: 4 stores
  • Madhya Pradesh: 4 stores
  • Puducherry: 5 stores
  • Delhi: 1 store

The stores increased with 108 net new stores added in Q2 FY2025, of which 71 were in Tier-2 and Tier-3 cities[3]

  • Market Cap 8,419 Cr.
  • Current Price 704
  • High / Low 849 / 598
  • Stock P/E 280
  • Book Value 101
  • Dividend Yield 0.00 %
  • ROCE 1.23 %
  • ROE 0.82 %
  • Face Value 2.00

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 41.5% CAGR over last 5 years
  • Company's working capital requirements have reduced from 545 days to 50.0 days

Cons

  • Stock is trading at 6.96 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Company has a low return on equity of 0.65% over last 3 years.
  • Promoters have pledged 54.2% of their holding.
  • Promoter holding has decreased over last 3 years: -56.2%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
56.20 24.71 38.82 27.29 42.45 57.24 86.95 71.89 98.67 148.10 148.37 178.33 156.23
52.23 25.16 41.05 28.83 42.88 53.50 75.53 69.57 92.43 137.31 135.44 160.02 139.28
Operating Profit 3.97 -0.45 -2.23 -1.54 -0.43 3.74 11.42 2.32 6.24 10.79 12.93 18.31 16.95
OPM % 7.06% -1.82% -5.74% -5.64% -1.01% 6.53% 13.13% 3.23% 6.32% 7.29% 8.71% 10.27% 10.85%
1.22 1.12 6.21 5.37 4.27 4.07 2.54 1.81 1.77 1.82 1.90 1.85 2.25
Interest 0.61 0.64 1.19 1.25 1.46 1.79 2.05 2.08 2.12 2.10 2.11 2.11 2.09
Depreciation 1.01 1.24 1.86 2.54 3.20 4.24 5.33 5.54 5.95 6.27 6.40 6.46 7.47
Profit before tax 3.57 -1.21 0.93 0.04 -0.82 1.78 6.58 -3.49 -0.06 4.24 6.32 11.59 9.64
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 65.17% 13.37% 0.00% 0.00% 24.76% -56.96% 20.28% 19.71%
3.56 -1.21 0.92 0.04 -0.82 0.62 5.71 -3.49 -0.06 3.19 9.92 9.24 7.75
EPS in Rs 1.11 -0.10 0.08 0.00 -0.07 0.05 0.48 -0.29 -0.01 0.27 0.83 0.77 0.65
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
2 2 2 9 10 61 68 146 214 467 631
6 7 4 14 13 86 77 142 208 435 572
Operating Profit -3 -5 -2 -5 -3 -25 -9 3 6 32 59
OPM % -137% -225% -89% -52% -36% -41% -13% 2% 3% 7% 9%
-1 1 0 1 1 2 2 10 23 7 8
Interest 1 0 0 12 0 0 1 3 7 8 8
Depreciation 0 0 0 0 0 1 1 5 15 24 27
Profit before tax -5 -4 -2 -16 -3 -24 -9 6 8 7 32
Tax % 0% 0% 0% 0% 0% 2% 0% 0% 27% -36%
-5 -4 -2 -16 -3 -25 -9 6 6 10 30
EPS in Rs -292.30 -241.71 -109.61 -793.71 -126.23 -1,220.91 -186.95 0.47 0.46 0.80 2.52
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 118%
3 Years: 90%
TTM: 100%
Compounded Profit Growth
10 Years: %
5 Years: 42%
3 Years: 46%
TTM: 983%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -13%
Return on Equity
10 Years: %
5 Years: 0%
3 Years: 1%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.17 0.17 0.17 0.19 0.19 0.19 0.45 24 24 24 24
Reserves 126 108 88 185 185 395 517 1,089 1,117 1,149 1,186
55 55 55 0 0 3 7 44 86 89 86
6 21 39 3 6 17 24 30 45 51 49
Total Liabilities 187 185 183 189 192 415 548 1,187 1,272 1,312 1,346
1 1 0 0 0 7 23 85 179 192 181
CWIP 0 0 0 0 0 1 2 16 18 0 2
Investments 153 177 177 181 186 381 408 418 917 930 926
34 6 5 8 5 26 115 668 157 190 237
Total Assets 187 185 183 189 192 415 548 1,187 1,272 1,312 1,346

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-5 -4 -2 -1 -1 -0 -6 -18 11 8
-11 -24 0 -2 -3 -194 -15 -636 32 -24
46 0 0 7 0 204 97 569 -8 -6
Net Cash Flow 30 -28 -1 4 -4 10 76 -86 35 -23

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 32 29 14 22 80 51 62 53 64 51
Inventory Days 33 35 12 16 15
Days Payable 9 17 17 30 19
Cash Conversion Cycle 32 29 14 22 80 75 79 48 50 47
Working Capital Days -78 -72 -130 -97 -145 -11 -16 1,554 30 50
ROCE % -2% -1% -2% -1% -8% -2% 1% 1% 1%

Shareholding Pattern

Numbers in percentages

17 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
40.43% 40.43% 40.43% 40.43% 40.43% 40.43% 40.43% 40.41% 40.45% 40.39% 40.39% 40.39%
3.42% 2.97% 3.15% 3.74% 3.94% 4.48% 4.87% 12.36% 12.96% 14.94% 14.85% 14.72%
27.72% 29.24% 29.48% 28.84% 28.77% 28.16% 28.13% 25.50% 25.19% 22.47% 22.17% 27.98%
28.08% 27.01% 26.58% 26.64% 26.56% 26.73% 26.42% 21.61% 21.31% 22.10% 22.51% 16.85%
0.35% 0.35% 0.35% 0.35% 0.29% 0.19% 0.15% 0.12% 0.10% 0.10% 0.08% 0.07%
No. of Shareholders 1,02,77982,62777,11976,97274,70273,51270,01766,43066,04874,97676,93487,328

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents